NEW YORK (GenomeWeb) – MediSapiens has announced that it will provide its software solution, dubbed the Integrated Genomics Platform, to Bayer Healthcare.
MediSapiens' solution will provide researchers at Bayer with centralized access to genomics data used in the pharma company. It will provide access to a vast collection of clinical genomics data as well as tools for analyzing, visualizing, and storing data.
Financial and other terms of the agreement were not disclosed.
In 2012, Bayer Healthcare licensed MediSapiens' OncoGenomics Explorer, a cloud-computing-based application designed for cancer genomics research, for use in its target discovery and drug repositioning projects.